Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity?

DNA and Cell Biology

Volumn 25, Issue 3, 2006, Pages 165-170

  Block, Timothy M ^a   Mehta, Anand S ^a   Blumberg, Baruch S ^b   Dwek, Raymond A ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONICITY; COMPLEX FORMATION; HEPATITIS B VIRUS; HEPATITIS C; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MORPHOGENESIS; NONHUMAN; OLIGOMERIZATION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN POLYMERIZATION; PROTEIN STRUCTURE; VIRUS ENVELOPE; VIRUS MORPHOLOGY; VIRUS RESISTANCE;

ANIMALS; EPITOPES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; KINETICS; MODELS, IMMUNOLOGICAL; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 33645529316     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2006.25.165     Document Type: Article

References (38)

1. BLOCK, T.M., and JORDAN, R. (2002). Imino sugars as possible broad spectrum anti hepatitis agents: The alkovirs and the glucovirs. Antiviral Chem. Chemother. 12, 317-326.
2. BLOCK, T.M., MEHTA, A.S., FIMMEL, C.J., and JORDAN, R. (2003). Molecular viral oncology of hepatocellular carcinoma. Oncogene 22, 5093-5107.
3. CHISARI, F.V. (2000). Viruses, immunity and cancer, lessons from hepatitis B. Am. J. Pathol. 156, 1118-1132.
4. CHOUKHI, A., PILLEZ, A., DROBECQ, H., SERGHERAERT, C., WYCHOWSKI, C., and DUBUISSON, J. (1999). Characterization of aggregates of hepatitis C virus glycoproteins. J. Gen. Virol. 80(Pt 12), 3099-3107.
5. CRESSWELL, P. (2004). Cell biology. Cutting and pasting antigenic peptides. Science 304, 587-590.
6. DUBUISSON, J., and RICE, C.M. (1996). Hepatitis C virus glycoprotein folding: Disulfide bond formation and association with calnexin. J. Virol. 70, 778-786.
7. FERRARI, C., PENNA, A., BERTOLETTI, A., VALLI, A., ANTONI, A.D., GUIBERTI, T., CAVALLI, A., PETIT, M.A., and FIACCADORI, F. (1990). Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145, 3442-3449.
8. GANEM, D., and PRINCE, A.M. (2004). Hepatitis B infection: Natural history and clinical consequences. N. Engl. J. Med. 350, 1118-1129.
9. GEISSLER, M., BRUSS, V., MICHALAK, S., HOCKENJOS, B., ORTMANN, D., OFFENSPERGER, W.B., WANDS, J.R., and BLUM, H.E. (1999). Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. J. Virol. 73, 4284-4292.
10. GIL-TORREGROSA, B.C., CASTANO, A.R., LOPEZ, D., and DEL VAL, M. (2000). Generation of MHC class I peptide antigens by protein processing in the secretory route by furin. Traffic 1, 641-651.
11. GOLIVINA, T.N., MORRISON, S.E., and EISENLOHR, L.C. (2005). The impact of misfolding versus targeted degradation on the efficiency of MHC class I restricted antigen processing. J. Immunol. 174, 2763-2769.
12. GUIDOTTI, L.G., ROCHFORD, R., CHUNG, J., SHAPIRO, M., PURCELL, R., and CHISARI, F.V. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-829.
13. KESKINEN, P., NYQVIST, M., SARENEVA, T., PIRHONEN, J., MELEN, K., and JULKUNEN, I. (1999). Impaired antiviral response in human hepatoma cells. Virology 263, 364-375.
14. KNOLLE, P.A., and GERKEN, G. (2000). Local control of the immune response in the liver. Immunol. Rev. 174, 21-34.
15. LAUTENSCHLAGER, I., and HAYRY, P. (1981). Expression of the major histocompatibility complex antigens on different liver cellular components in rat and man. Scand. J. Immunol. 14, 421-426.
16. LAU, A.H., DE CREUS, A., LU, L., and THOMSON, A.W. (2003). Liver tolerance mediated by antigen presenting cells: Fact or fiction? Gut 52, 1075-1078.
17. LYBARGER, L., WANG, X., HARRIS, M., and HANSEN, T.H. (2005). Viral immune evasion molecules attack the ER peptide loading complex and exploit ER associated degradation pathways. Curr. Opin. Immunol. 17, 71-78.
18. MENNE, S., MASCHKE, J., LU, M., GROSSE-WILDE, H., and ROGGENDORF, M. (1998). T-cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J. Virol. 72, 6083-6091.
19. MICHALAK, T.I., HODGSON, P.D., and CHURCHILL, N.D. (2000). Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection. J. Virol. 74, 4483-4494.
20. MILICH, D.R. (1997). Pathobiology of acute and chronic hepatitis B virus infection: An introduction. J. Viral Hepatitis 4, 25-30.
21. MILICH, D., and LIANG, T.J. (2003). Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38, 1075-1086.
22. PAMER, E., and CRESWELL, P. (1998). Mechanisms of MHC class I antigen presentation. Annu Rev. Immunol. 16, 323.
23. RECANELLI, V., and REHERMANN, B. (2006). The liver as an immunological organ. Hepatology 43, S54-S62 [Epub ahead of print].
24. REHERMANN, B. (2000). Intrahepatic T cells in hepatitis B: Viral control versus liver cell injury. J. Exp. Med. 191, 1263-1268.
25. REHERMANN, B., and NASCIMBENI, M. (2005). Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5, 215-229.
26. REHERMANN, B., LAU, D., HOOFNAGLE, J.H., and CHISARI, F.V. (1996). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B infection. J. Clin. Invest. 97, 1655-1665.
27. REIGNAT, S., WEBSTER, G.J.M., BROWN, D., OGG, G.S., KING, A., SENEVIRATNE, S.L., DUSHEIKO, G., WILLIAMS, R., MAINI, M.K., and BERTOLETTI, A. (2002). Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J. Exp. Med. 195, 1089-1101.
28. SCHIRMBECK, R., ZHENG. X., ROGGENDORF, M., GEISSLER, M., CHISARI, F.V., REIMANN, J., and LU, M. (2001). Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J. Immunol. 166, 1405-1413.
29. SING, G.K., LI, D., CHEN, X., MACNAUGHTON, T., LICHANSKA, A.M., BUTTERWORTH, L., LADHAMS, A., and COOKSLEY, G. (2001). A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: Evidence for antigen driven selection of a public complementarity determining region 3 (CDR3) motif. Hepatology 33, 1288-1298.
30. SIMSEK, E., MEHTA, A., ZHOU, T., DWEK, R., and BLOCK, T. (2005). HBV large and middle glycoproteins appear to be degraded by a proteasome pathway in glucosidase inhibited cells but not in cells with functional glucosidase enzyme. J. Virol. 79, 12914-12920.
31. TOWNSEND, A., BASTIN, J., GOULD, K., BROWNLEE, G., ANDREW, M., COUPAR, B., BOYLE, D., CHAN, S., and SMITH, G. (1988). Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168, 1211-1224.
32. VANLANDSCHOOT, P., HOUTTE, F.V., ROOBROUCK, A., FARHOUDI, A., and LEROUX-ROELS, G. (2002). Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte specific receptor. J. Gen. Virol. 83, 1281-1289.
33. VINGERHOETS, J., MICHIELSEN, P., VANHAM, G., BOSMANS, E., PAULIJ, W., RAMON, A., PELCKMANS, P., KESTENS, L., and LEROUX-ROESL, G. (1998). HBV specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J. Hepatol. 28, 8-16.
34. VOEHRINGER, D., BLASER, C., GRAWITZ, A., CHISARI, F., BUERKI, K., and PIRCHER, H. (2000). Break of T cell ignorance to a viral antigen in the liver induces to hepatitis. J. Immunol. 166, 1389-1397.
35. WEBSTER, J.M.G., REIGNAT, S., MAINI, M.K., WHALLEY, S.A., OGG, G.S., KING, A., BROWN, D., AMLOT, P.L., WILLIAMS, R., VERGANI, D., DUSHEIKO, G.M., and BERTOLETTI, A. (2000). Incubation phase of acute hepatitis B in man: Dynamics of cellular immune mechanisms. Hepatology 32, 1117-1124.
36. YEWDELL, J.W. (2003). Hide and seek in the peptidome. Science 301, 1334-1335.
37. YORK, I.A., and ROCK, K.L. (1996). Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 4, 369-396.
38. ZHENG, B.J., ZHOU, J., QU, D., SIU, K.L., LAM, T.W., LO, H.Y., LEE, S.S., and WEN, Y.M. (2004). Selective functional deficit in dendritic cell-T cell interaction is a crucial mechanism in chronic hepatitis B virus infection. J. Viral Hepatitis 11, 217-224.